(Q34686955)

English

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments (English)

1 reference

Europe PubMed Central

3 August 2017

multiple sclerosis

0 references

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

object named as

Peter Connick

1

0 references

object named as

Rickie Patani

3

0 references

David L. Thomas

object named as

David L Thomas

13

0 references

Alan J. Thompson

object named as

Alan J Thompson

18

0 references

Rebecca S Samson

object named as

Rebecca S Samson

12

0 references

Alastair Compston

20

object named as

Alastair Compston

1 reference

Europe PubMed Central

3 August 2017

David H. Miller

19

object named as

David H Miller

1 reference

Europe PubMed Central

3 August 2017

17

object named as

Daniel R Altmann

1 reference

Europe PubMed Central

3 August 2017

Madhan Kolappan

2

object named as

Madhan Kolappan

1 reference

Europe PubMed Central

3 August 2017

Claudia Wheeler-Kingshott

10

object named as

Claudia A M Wheeler-Kingshott

1 reference

Europe PubMed Central

3 August 2017

11

object named as

Daniel J Tozer

1 reference

Europe PubMed Central

3 August 2017

Siddharthan Chandran

21

object named as

Siddharthan Chandran

1 reference

Europe PubMed Central

3 August 2017

author name string

Michael A Scott

4

1 reference

Europe PubMed Central

3 August 2017

Charles Crawley

5

1 reference

Europe PubMed Central

3 August 2017

Xiao-Ling He

6

1 reference

Europe PubMed Central

3 August 2017

Karen Richardson

7

1 reference

Europe PubMed Central

3 August 2017

Kelly Barber

8

1 reference

Europe PubMed Central

3 August 2017

Daniel J Webber

9

1 reference

Europe PubMed Central

3 August 2017

Ming-Qing Du

14

1 reference

Europe PubMed Central

3 August 2017

Shi L Luan

15

1 reference

Europe PubMed Central

3 August 2017

Andrew W Michell

16

1 reference

Europe PubMed Central

3 August 2017

publication date

2 March 2011

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

12

1 reference

Europe PubMed Central

3 August 2017

62

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

2 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1745-6215-12-62

0 references

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

3D MDEFT imaging of the human brain at 4.7 T with reduced sensitivity to radiofrequency inhomogeneity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Adaptive cortical plasticity in higher visual areas after acute optic neuritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

7 July 2018

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-62

21 January 2018

Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-62

21 January 2018

Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-62

21 January 2018

Statistical parametric maps in functional imaging: A general linear approach

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-62

21 January 2018

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-62

21 January 2018

Primary progressive multiple sclerosis: a 5-year clinical and MR study.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-62

21 January 2018

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

26 October 2018

Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3059276

26 October 2018

Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The course of multiple sclerosis in 73 cases with computer-designed curves

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High contrast and fast three-dimensional magnetic resonance imaging at high fields

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo diffusion tensor imaging of the human optic nerve: Pilot study in normal controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/21366911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-12-62

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34686955&oldid=1807764903"